{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T14:55:20Z","timestamp":1761058520271},"reference-count":15,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2007,1,1]],"date-time":"2007-01-01T00:00:00Z","timestamp":1167609600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Contraception"],"published-print":{"date-parts":[[2007,1]]},"DOI":"10.1016\/j.contraception.2006.08.004","type":"journal-article","created":{"date-parts":[[2006,9,21]],"date-time":"2006-09-21T07:29:00Z","timestamp":1158823740000},"page":"16-22","source":"Crossref","is-referenced-by-count":57,"title":["Efficacy and safety of a new 24-day oral contraceptive regimen of norethindrone acetate 1 mg\/ethinyl estradiol 20 \u03bcg (Loestrin\u00ae 24 Fe)"],"prefix":"10.1016","volume":"75","author":[{"given":"Steven T.","family":"Nakajima","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David F.","family":"Archer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Herman","family":"Ellman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.contraception.2006.08.004_bib1","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1056\/NEJMcp030751","article-title":"Combination estrogen\u2013progestin oral contraceptives","volume":"349","author":"Petitti","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.contraception.2006.08.004_bib2","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0010-7824(02)00445-6","article-title":"Bleeding patterns and patient acceptability of standard or continuous dosing regimens of a low-dose oral contraceptive: a randomized trial","volume":"67","author":"Kwiecien","year":"2003","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2006.08.004_bib3","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S0010-7824(99)00043-8","article-title":"Preferred frequency and characteristics of menstrual bleeding in relation to reproductive status, oral contraceptive use, and hormone replacement therapy use","volume":"59","author":"den Tonkelaar","year":"1999","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2006.08.004_bib4","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1067\/mob.2001.117416","article-title":"Current perspectives on oral contraceptive use","volume":"185","author":"Burkman","year":"2001","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.contraception.2006.08.004_bib5","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S0010-7824(99)00109-2","article-title":"Efficacy, cycle control, and side effects of low- and lower-dose oral contraceptives: a randomized trial of 20 \u03bcg and 35 \u03bcg estrogen preparations","volume":"60","author":"Rosenberg","year":"1999","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2006.08.004_bib6","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0010-7824(01)00235-9","article-title":"Open, multicenter comparison of efficacy, cycle control, and tolerability of a 23-day oral contraceptive regimen with 20 \u03bcg ethinyl estradiol and 75 \u03bcg gestodene and a 21-day regimen with 20 \u03bcg ethinyl estradiol and 150 \u03bcg desogestrel","volume":"64","author":"Endrikat","year":"2001","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2006.08.004_bib7","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1006\/rtph.2001.1483","article-title":"Pharmacology and toxicology of ethinyl estradiol and norethindrone acetate in experimental animals","volume":"34","author":"Maier","year":"2001","journal-title":"Regul Toxicol Pharmacol"},{"key":"10.1016\/j.contraception.2006.08.004_bib8","series-title":"Managing contraceptive pill patients","first-page":"10","article-title":"Benefits of OCs to reproductive health","author":"Dickey","year":"2002"},{"issue":"Suppl","key":"10.1016\/j.contraception.2006.08.004_bib9","doi-asserted-by":"crossref","first-page":"S39","DOI":"10.1016\/S0002-9378(99)70362-5","article-title":"Efficacy and safety of a low-dose monophasic combination oral contraceptive containing 100 \u03bcg levonorgestrel and 20 \u03bcg ethinyl estradiol (Alesse\u00ae)","volume":"181","author":"Archer","year":"1999","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.contraception.2006.08.004_bib10","doi-asserted-by":"crossref","first-page":"S302","DOI":"10.1016\/S0002-9378(99)70722-2","article-title":"\u201cEstrophasic\u201d dosing: a new concept in oral contraceptive therapy","volume":"180","author":"Rowan","year":"1999","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.contraception.2006.08.004_bib11","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0010-7824(97)00024-3","article-title":"A new low-dose monophasic combination oral contraceptive (Alesse\u2122) with levonorgestrel 100 \u03bcg and ethinyl estradiol 20 \u03bcg","volume":"55","author":"Archer","year":"1997","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2006.08.004_bib12","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/S0149-2918(00)88272-7","article-title":"International clinical experience with a new low-dose, monophasic oral contraceptive containing levonorgestrel 100 \u03bcg and ethinyl estradiol 20 \u03bcg","volume":"21","author":"Boerrigter","year":"1999","journal-title":"Clin Ther"},{"key":"10.1016\/j.contraception.2006.08.004_bib13","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/S0010-7824(03)00069-6","article-title":"Efficacy, safety and cycle control of five oral contraceptive regimens containing norgestimate and ethinyl estradiol","volume":"67","author":"LaGuardia","year":"2003","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2006.08.004_bib14","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0010-7824(99)00026-8","article-title":"Clinical comparison of triphasic norgestimate\/35 \u03bcg ethinyl estradiol and monophasic norethindrone acetate\/20 \u03bcg ethinyl estradiol: cycle control, lipid effects, and user satisfaction","volume":"59","author":"Sulak","year":"1999","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2006.08.004_bib15","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/S0002-9378(98)70047-X","article-title":"Oral contraceptive discontinuation: a prospective evaluation of frequency and reasons","volume":"179","author":"Rosenberg","year":"1998","journal-title":"Am J Obstet Gynecol"}],"container-title":["Contraception"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782406003179?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782406003179?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,12]],"date-time":"2019-01-12T21:25:30Z","timestamp":1547328330000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0010782406003179"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,1]]},"references-count":15,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007,1]]}},"alternative-id":["S0010782406003179"],"URL":"https:\/\/doi.org\/10.1016\/j.contraception.2006.08.004","relation":{},"ISSN":["0010-7824"],"issn-type":[{"value":"0010-7824","type":"print"}],"subject":[],"published":{"date-parts":[[2007,1]]}}}